Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Tiotropium Formulations in COPD
NCT02242266Phase 2Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jul 2005
- Primary completion
- Jun 2006
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial of tiotropium in chronic obstructive pulmonary disease (COPD) (4 arms), sponsored by Boehringer Ingelheim. Primary endpoint: Area under the curve for the time period 0 to 12 hours of forced expiratory volume in one second. Started Jul 2005; status: completed.
02
Drugs
tiotropium
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02242266.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02242266.